The Identification of Factors Linked to the Potential Acceptance of Transgenic Biopharmaceuticals: An Exploratory Study

By Duguay Francois   Katsanis Lea P.   Thakor Mrugank V.  

Health Marketing Quarterly, Vol. 21, Iss. 1-2, 2004-07 ,pp. : 65-89

Haworth Press

Access to resources Recommend Favorite

Oligoarginine-PEG-lipid particles for gene delivery

By Maitani Yoshie   Hattori Yoshiyuki  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 10, 2009-10 ,pp. : 1065-1077

Informa Healthcare

Access to resources Recommend Favorite

Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco

By Tackaberry E.S.   Dudani A.K.   Prior F.   Tocchi M.   Sardana R.   Altosaar I.   Ganz P.R.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3020-3029

Elsevier

Access to resources Recommend Favorite

Genetically Modified Organisms and Food

By Marshall Stewart  

Nutrition & Food Science, Vol. 94, Iss. 1, 1994-01 ,pp. : 4-7

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

By Garay Ricardo P   El-Gewely Raafat   Armstrong Jonathan K   Garratty George   Richette Pascal  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 11, 2012-11 ,pp. : 1319-1323

Informa Healthcare

Access to resources Recommend Favorite